Hers GLP-1 treatments use semaglutide or tirzepatide, which aid weight loss when prescribed alongside diet and activity.
Curious whether the women’s telehealth platform’s GLP-1 offering actually helps? Here’s a clear, ad-safe rundown grounded in clinical data on semaglutide and tirzepatide, plus how the Hers process, pricing, side effects, and buyer reviews translate into real-world results.
What GLP-1 Medicines Do
GLP-1 receptor agonists slow gastric emptying, reduce appetite, and support caloric control. The two names you’ll see in many weight programs are semaglutide and tirzepatide. Semaglutide is the active ingredient in brands like Wegovy and Ozempic; tirzepatide is found in Zepbound and Mounjaro. In large trials, both led to meaningful weight change when paired with lifestyle guidance. In a head-to-head study, tirzepatide produced larger average losses at 72 weeks, while semaglutide also showed strong outcomes in multiple trials. Your response, tolerance, and access will shape which option a prescriber selects.
Fast Facts: Medicines, Outcomes, Side Effects
| Medication | Clinical Weight Loss (trial data) | Common Side Effects |
|---|---|---|
| Semaglutide (weekly) | ~15% average body-weight reduction at ~68 weeks in non-diabetic adults on lifestyle support | Nausea, vomiting, diarrhea, constipation, headache |
| Tirzepatide (weekly) | ~20% average body-weight reduction at ~72 weeks; larger losses vs semaglutide in a 72-week comparison | GI symptoms like nausea, diarrhea, decreased appetite; injection-site reactions |
| Liraglutide (daily) | Lower average losses vs weekly agents; still helpful for some patients | GI symptoms, fatigue, injection-site reactions |
Do Hers GLP-1 Plans Work: What Reviews Say
Program success usually tracks three things: the right candidate, steady dose escalation, and adherence to a simple lifestyle plan. The platform connects you to licensed prescribers who screen for eligibility, review your history, and choose a path that can include semaglutide, tirzepatide, or a non-GLP-1 option. Patient stories often mention reduced appetite within weeks, a smoother relationship with food, and steadier progress when check-ins keep dosage and side effects on track.
Expect variability. Some users see double-digit percent loss by month six to nine; others move slower because of dose limits, intolerance, medication access, or life stress. A fair read of reviews shows the biggest wins when people stay on plan, meet protein targets, and keep light activity in their week.
How The Hers Process Works
- Online intake: Health questionnaire, weight history, and goals.
- Clinician review: A licensed provider reviews the intake, may request labs, and weighs risks vs benefits.
- Medication path: If appropriate, a GLP-1 or alternative is prescribed; supply source can be brand or pharmacy partner based on availability.
- Dose escalation: Slow titration helps GI tolerance and keeps you on therapy.
- Follow-ups: Messaging and check-ins adjust dose, manage side effects, and reinforce habits.
Who Tends To Be A Good Fit
Adults with obesity, or with overweight plus a weight-related condition (such as prediabetes), often qualify. People who prefer once-weekly injections and can commit to months of use tend to do well. Those pregnant or breastfeeding, with a history of certain endocrine tumors, or with past pancreatitis need different care. Your prescriber will screen for these and other red flags.
Benefits And Limits To Expect
Appetite control: Many users report fewer cravings and smaller portions without white-knuckle willpower. That creates a calorie gap without strict rules or complex tracking.
Plateau management: Dose increases and simple habit tweaks can restart progress. If GI effects get in the way, a slower ramp or a lateral medication switch may help.
Long game: GLP-1s work while you take them. Stopping often brings some regain. Building repeatable meals, daily steps, and sleep routines keeps more of the loss.
What The Science Says
Peer-reviewed trials show clear weight change with weekly GLP-1s over 68–72 weeks, plus waist reduction and metabolic benefits. A large comparison found tirzepatide reduced weight and waist more than semaglutide at week 72. For semaglutide, continued use helped maintain losses, while stopping led to regain. These patterns match many patient reviews: the medicine lowers the friction, and habits lock the result in place.
Side Effects And Safety
GI symptoms are the main complaint. Nausea is common early, then tends to ease with time and dose pacing. Hydration, protein-forward meals, and pausing alcohol can help. Call your prescriber for persistent vomiting, severe abdominal pain, or signs of dehydration. Rare risks (gallbladder issues, pancreatitis, thyroid C-cell tumors in rodent studies) are part of the screening discussion.
Be cautious with unapproved or counterfeit products. U.S. regulators have flagged fraudulent and unapproved GLP-1 versions sold online. If a plan includes pharmacy partners, ask where the medication is filled and whether it is an FDA-approved brand. Read labels and ask for clarity on ingredients and lot numbers.
Price, Access, And What You Get
Costs vary by medication, dose, and insurance. Public statements from the company mention entry-level pricing for GLP-1 access that undercuts brand cash prices, with availability routed through pharmacy partners. Supply shifts can change timelines, so plan for some flexibility. Check your state’s rules and your pharmacy benefit details before you start.
Plan Snapshot: What’s Typically Included
| Plan Item | What You Get | Typical Range |
|---|---|---|
| Initial consult | Provider intake, eligibility review, risk screening | One-time fee or rolled into first month |
| Medication | GLP-1 prescription if appropriate; dose escalation | Monthly pricing varies by drug and dose |
| Care access | Messaging, follow-ups, refills, dose changes | Included while subscribed |
How To Get The Most From Treatment
Smart Habits That Compound Results
- Protein target: Aim for a protein source at each meal. Many users find 25–35 grams per meal helps satiety and preserves lean mass.
- Produce and fiber: Add vegetables and fruit daily. A simple plate rule—half produce, a palm of protein, a cupped-hand of starch—keeps portions steady.
- Steps and strength: A walking routine plus two short strength sessions per week helps waist change and energy.
- Slow escalation: Follow the titration plan. Jumping doses can spike nausea and derail adherence.
- Meal timing: Smaller, earlier meals often sit better during ramp-up weeks.
- Hydration and sleep: Both ease GI symptoms and help cravings.
Managing Side Effects Without Derailing Progress
- Nausea: Tiny, frequent meals; ginger tea; skip high-fat foods during early weeks.
- Constipation: Fluid, fiber, and a short walk after meals; talk with your provider before adding laxatives.
- Headache: Hydration and regular meals; flag persistent symptoms to your clinician.
Who Should Skip Or Pause
People with a history of medullary thyroid carcinoma or MEN2 should not take these agents. Those pregnant, planning pregnancy, or breastfeeding need alternatives. Report any past pancreatitis, gallbladder disease, or severe GI disorders, and review all meds that slow gastric emptying. If you use diabetes therapy, dosing may need careful coordination to avoid hypoglycemia.
What Real-World Timelines Look Like
Weeks 1–4: Appetite decline shows up for many during the first or second dose step. The scale may budge a few pounds, often from a mix of water and intake change.
Weeks 5–12: With dose increases, energy intake drops further. Many users report looser clothes and a steadier weekly trend. GI symptoms often cool off here.
Months 3–6: Double-digit percent loss is common among adherent users. Reviews describe more freedom around food choices and less mindshare spent on cravings.
Months 6–12: Plateaus happen. Dose adjustments, fiber tweaks, and a small bump in daily steps tend to restart the line. If supply or cost issues hit, work with your prescriber on bridging options.
How Hers Compares To A Local Clinic
Telehealth offers speed, ongoing messaging, and home delivery. A local clinic may provide body-composition scans, labs on site, and in-person coaching. Many readers choose based on pharmacy access and how much hand-holding they want day to day. What matters most is safe prescribing, transparent sourcing, and steady follow-up.
Red Flags To Watch
- Unclear sourcing: If you can’t confirm the product is an FDA-approved brand, slow down and ask questions.
- Too-fast dose jumps: GI fallout can make you quit. Slow and steady keeps you in the game.
- Zero lifestyle help: Medicine drops appetite; habits keep the pounds off. Look for simple, repeatable guidance.
Final Take For Buyers
Hers connects eligible adults to GLP-1 medications with a virtual care layer that helps with dose changes and side-effect management. The medicines themselves—semaglutide and tirzepatide—carry strong clinical backing for weight loss when combined with practical habits. Results vary based on fit, consistency, and access, but many users land steady progress across months. If you like the ease of online care and you’re ready to pair the prescription with basic nutrition and movement, this route can be a clear path to measurable change. Always confirm sourcing, read the label, and keep your follow-ups active.
Evidence and safety context in this piece come from peer-reviewed trials and regulators. Read more via
semaglutide trial data and
tirzepatide vs semaglutide results, plus FDA guidance on
unapproved GLP-1 products.